Financials

  • Market Capitalization 32.86 M
  • Employee 162
  • Founded 2015
  • CEO N/A
  • Website www.gossamerbio.com
  • Headquarter Delaware, United States
  • FIGI BBG00MVWLLM2
  • Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-4.13
Rapporto prezzo/fatturato
14.62

Related tickers

#NomePrezzo24h %7d %1M %1Y %Valore di MercatoUltimi 7 Giorni
4446
RADX
Radiopharm Theranostics Limited American Depositary Shares
4.33 USD-0.92%+2.85%+2.85%+1.88%34.13 M USD
4452
LSTA
Lisata Therapeutics, Inc. - Common Stock
3.70 USD+13.15%+11.11%+5.11%+42.86%33.69 M USD
4461
BCTX
BriaCell Therapeutics Corp. - Common Shares
3.75 USD-4.82%+5.04%+31.12%+89.39%32.62 M USD
4464
LITS
Lite Strategy, Inc. - Common Stock
0.95 USD-5.94%-3.06%+21.79%-68.12%32.32 M USD

Notizie